Market Place
Sourcing Support
Novartis Posts Strong Q1 Growth, Reaffirms 2026 Guidance
28 Apr 2026 //
GLOBENEWSWIRE
Novartis CEO Concerned About Germany`s €60B Healthcare Spending
28 Apr 2026 //
ENDPOINTS
Novartis Cuts Hit New Jersey Again, Affecting 60 Employees
28 Apr 2026 //
BIOSPACE
Novartis Highlights First Quarter Earnings Call
28 Apr 2026 //
FIRSTWORD PHARMA
Novartis` Coartem Baby Granted WHO Prequalification
24 Apr 2026 //
GLOBENEWSWIRE
NCCN Honors Initiatives Advancing Leukemia CML Care
23 Apr 2026 //
PR NEWSWIRE
Novartis Narrows Anticoagulant`s Focus After Losing To Eliquis
22 Apr 2026 //
FIERCE BIOTECH
Novartis cuts two Programs in Cancer-Related Blood Clots
20 Apr 2026 //
ENDPOINTS
Novartis CEO Vas Narasimhan joins Anthropic board
20 Apr 2026 //
INDPHARMAPOST
NIPER Mohali And Novartis Partner To Enhance R&D Innovation
16 Apr 2026 //
INDPHARMAPOST
Novartis CEO Vas Narasimhan joins Anthropic`s board
16 Apr 2026 //
FIERCE PHARMA
Novartis Pumps Up Heart Disease, Cancer Community Health Plan
10 Apr 2026 //
FIERCE PHARMA
Novartis To Cut 114 More Jobs At New Jersey HQ
10 Apr 2026 //
FIERCE PHARMA
Novartis Expands Global Health Programs For Heart Disease
09 Apr 2026 //
GLOBENEWSWIRE
Novartis Pledges $480M for China Expansion Following Lilly and AZ
24 Mar 2026 //
BIOSPACE
Novartis Pledges Nearly $480M To Bolster China Production, R&D
23 Mar 2026 //
WEIXIN
Delhi HC Rebukes Patent Office For Delay In Breast Cancer Drug
18 Mar 2026 //
ECONOMICTIMES
Novartis Shareholders Approve Board Resolutions At AGM 2026
06 Mar 2026 //
GLOBENEWSWIRE
Novartis Settles Lawsuit With Estate Of Henrietta Lacks
24 Feb 2026 //
FIERCE PHARMA
Novartis to Exit India unit in $159M deal; Share Surge
21 Feb 2026 //
REUTERS
Trump meets Novartis CEO, says Drugmaker Building 11 US plants
19 Feb 2026 //
REUTERS
Novartis CEO Pay Soars 30% To $32M In 2025
09 Feb 2026 //
FIERCE PHARMA
Novartis: 2023 Growth, 40% Core Margin, Pipeline Wins
04 Feb 2026 //
GLOBENEWSWIRE
Novartis Super Bowl Ad Drafts NFL Stars For Prostate Cancer Push
29 Jan 2026 //
FIERCE PHARMA
Novartis Charts Next US Investment With New Radiopharma Plant
12 Jan 2026 //
FIERCE PHARMA
Tempus Achieves Record Total Contract Value Exceeding $1.1 B
11 Jan 2026 //
BUSINESSWIRE
Novartis, US Government Agree To Lower US Drug Prices
19 Dec 2025 //
GLOBENEWSWIRE
Novartis Builds Largest Global R&D Hub In India
18 Dec 2025 //
ECONOMICTIMES
Novartis Taps Salesforce Agentforce for Engagement Boost
17 Dec 2025 //
BUSINESSWIRE
Novartis Names Vrinda Taneja Director Of People & Organization
14 Dec 2025 //
INDPHARMAPOST
Novartis Ground on Flagship Manufacturing Hub in North Carolina
12 Dec 2025 //
GLOBENEWSWIRE
Novartis To Cut 550 Jobs At Swiss Facility By End Of 2027
25 Nov 2025 //
FIERCE PHARMA
Novartis Forecasts 5-6% Sales Growth Through 2030
20 Nov 2025 //
GLOBENEWSWIRE
Novartis Opens New Plant in California to Make Cancer Drugs
11 Nov 2025 //
REUTERS
Novartis` Pluvicto Heavywork Proves Radiopharma Can Succeed
06 Nov 2025 //
BIOSPACE
Novartis India Posts Q2 FY26 PAT At Rs. 24.22 Cr
30 Oct 2025 //
INDPHARMAPOST
Novartis CEO Criticizes Trump`s Drug Pricing Deals
28 Oct 2025 //
BIOSPACE
Novartis Reports Strong Q3; Sales Growth And Pipeline Progress
28 Oct 2025 //
GLOBENEWSWIRE
Novartis Announces Expiration Of Tourmaline Bio Tender Offer
28 Oct 2025 //
GLOBENEWSWIRE
Novartis Completes Acquisition Of Tourmaline Bio
28 Oct 2025 //
GLOBENEWSWIRE
Newer Drugs Came To Novartis` Aid As 2 Top-Selling Brands Stalled
28 Oct 2025 //
FIERCE PHARMA
Novartis Presents Immunology Breakthroughs At ACR Congress
25 Oct 2025 //
GLOBENEWSWIRE
Novartis Completes Hart-Scott-Rodino Waiting Period
22 Oct 2025 //
GLOBENEWSWIRE
Arrowhead Pharma Finalizes Collaboration Deal with Novartis
21 Oct 2025 //
BUSINESSWIRE
Novartis` Fabhalta Slows Kidney Decline In Iga Nephropathy
16 Oct 2025 //
GLOBENEWSWIRE
Novartis Survey Explores Women`s Feelings About Breast Health
07 Oct 2025 //
FIERCE PHARMA
Novartis` Skin Disease Drug Gets Us Approval
01 Oct 2025 //
REUTERS
Novartis Earns FDA Ire For `misleading` Fabhalta Ad Imagery
30 Sep 2025 //
FIERCE PHARMA
Novartis, Boehringer Debut DTC Programs With Reduced Drug Prices
29 Sep 2025 //
FIERCE PHARMA
Novartis Initiates Tender Offer For Tourmaline Bio Acquisition
29 Sep 2025 //
GLOBENEWSWIRE
Novartis To Present Breakthrough Data On Prostate & Breast Cancer
26 Sep 2025 //
GLOBENEWSWIRE
Novartis Seeks Solutions To Lower Us Bring Down Drug Costs in US
22 Sep 2025 //
BIOSPACE
6 Pharma Layoffs Could Eliminate Over 39,000 Jobs
18 Sep 2025 //
BIOSPACE
Novartis Signs up to $5.7 B licensing deal with Monte Rosa
15 Sep 2025 //
REUTERS
Novartis Falls in Another IRA Price Negotiation Loss for Pharma
12 Sep 2025 //
FIERCE PHARMA
Novartis to Acquire Tourmaline Bio for $1.4 Billion
09 Sep 2025 //
REUTERS
Novartis Plans 58 Layoffs in N.J.
02 Sep 2025 //
FIERCE PHARMA
Gateway to Growth: Innovation and Opportunity at the 8th CIIE
01 Sep 2025 //
BUSINESSWIRE
Novartis ESC Data Showcases Cardiovascular Portfolio Strength
18 Aug 2025 //
GLOBENEWSWIRE
FDA Approves Novartis` Leqvio (Inclisiran) for First-Line Use
31 Jul 2025 //
PR NEWSWIRE
